Skip navigation

Dr Roben Gieling

Senior Lecturer

Department: Applied Sciences

Roben Gieling Academic Staff, Faculty of Life and Health Sciences, Northumbria University  Roben began his scientific career in Biomedical Science with the University of Utrecht (Master’s programme in Medical Biology), which included two placements in the University Medical Centre Utrecht, and graduated in 1997.

His time as scientific staff with the RWTH Aachen University (Neurology Department 1997-98) was followed by a postgraduate study at the University of Amsterdam (Department of Anatomy and Embryology) on “Changes in Blood Flow that Affect Hepatic Gene Expression”, where he received a PhD in Medicine in 2005.

Roben undertook postdoctoral research in world leading research groups at USC Los Angeles (Prof Han), Newcastle University (Prof Mann) and the University of Manchester (Prof Williams) contributing to 19 highly regarded papers, in Oncology, Imaging and Hepatology fields. In his role as guest lecturer and tutor he contributed to the Pharmacy and Medicine undergraduate education in the University of Manchester. There he supervised  3 PhD students

He joined the Department of Applied Sciences in July 2018 as Senior Lecturer in Histopathology where he will contribute to the Biomedical Science programmes, and use his expertise to establish his own research group.

Campus Address

NB148, Northumberland Building
Northumbria University
Newcastle upon Tyne
NE21HL

Key Publications

  • Please visit the Pure Research Information Portal for further information
  • A new method for the high-precision assessment of tumor changes in response to treatment, Tar, P., Thacker, N., Babur, M., Watson, Y., Cheung, S., Little, R., Gieling, R., Williams, K., O'Connor, J. 14 Mar 2018, In: Bioinformatics
  • Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer, Bryant, J., Meredith, S., Gieling, R., Allen, T., Walker, L., Telfer, B., Supuran, C., Williams, K., White, A. 1 Jan 2018, In: International Journal of Cancer
  • The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy, van Kuijk, S., Gieling, R., Niemans, R., Lieuwes, N., Biemans, R., Telfer, B., Haenen, G., Yaromina, A., Lambin, P., Dubois, L., Williams, K. 11 Aug 2016, In: PLoS One
  • Dissemination via the lymphatic or angiogenic route impacts the pathology, microenvironment and hypoxia-related drug response of lung metastases, Gieling, R., Fitzmaurice, R., Telfer, B., Babur, M., Williams, K. Aug 2015, In: Clinical and Experimental Metastasis
  • NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma, Wilson, C., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A., Gieling, R., Chakraborty, J., Fox, C., Richardson, C., Callaghan, K., Blair, G., Fox, N., Lagnado, A., Passos, J., Moore, A., Smith, G., Tiniakos, D., Mann, J., Oakley, F., Mann, D. 16 Apr 2015, In: Nature Communications
  • Targeting tumour hypoxia to prevent cancer metastasis, Pettersen, E., Ebbesen, P., Gieling, R., Williams, K., Dubois, L., Lambin, P., Ward, C., Meehan, J., Kunkler, I., Langdon, S., Ree, A., Flatmark, K., Lyng, H., Calzada, M., Peso, L., Landazuri, M., Görlach, A., Flamm, H., Kieninger, J., Urban, G., Weltin, A., Singleton, D., Haider, S., Buffa, F., Harris, A., Scozzafava, A., Supuran, C., Moser, I., Jobst, G., Busk, M., Toustrup, K., Overgaard, J., Alsner, J., Pouyssegur, J., Chiche, J., Mazure, N., Marchiq, I., Parks, S., Ahmed, A., Ashcroft, M., Pastorekova, S., Cao, Y., Rouschop, K., Wouters, B., Koritzinsky, M., Mujcic, H., Cojocari, D. 3 Sep 2015, In: Journal of Enzyme Inhibition and Medicinal Chemistry
  • [18F]-FLT Positron Emission Tomography Can Be Used to Image the Response of Sensitive Tumors to PI3-Kinase Inhibition with the Novel Agent GDC-0941, Cawthorne, C., Burrows, N., Gieling, R., Morrow, C., Forster, D., Gregory, J., Radigois, M., Smigova, A., Babur, M., Simpson, K., Hodgkinson, C., Brown, G., McMahon, A., Dive, C., Hiscock, D., Wilson, I., Williams, K. May 2013, In: Molecular Cancer Therapeutics
  • Carbonic anhydrase IX as a target for metastatic disease, Gieling, R., Williams, K. 15 Mar 2013, In: Bioorganic and Medicinal Chemistry
  • Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro, Gieling, R., Parker, C., De Costa, L., Robertson, N., Harris, A., Stratford, I., Williams, K. 1 Apr 2013, In: Journal of Enzyme Inhibition and Medicinal Chemistry
  • Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts, Gieling, R., Babur, M., Mamnani, L., Burrows, N., Telfer, B., Carta, F., Winum, J., Scozzafava, A., Supuran, C., Williams, K. 14 Jun 2012, In: Journal of Medicinal Chemistry


+

Northumbria Open Days

Open Days are a great way for you to get a feel of the University, the city of Newcastle upon Tyne and the course(s) you are interested in.

Research at Northumbria
+

Research at Northumbria

Research is the life blood of a University and at Northumbria University we pride ourselves on research that makes a difference; research that has application and affects people's lives.

+

Order your prospectus

If you would like to know more about our courses, or life in general as a student at Northumbria, then we can help you.

Latest News and Features

More news
More events

Upcoming events

Iwin Mitchell - Quiz Our Trainees
Brexit and Internal Security

Back to top